![Damian deGoa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Damian deGoa
Direktor/Vorstandsmitglied bei
LIQUIDIA CORPORATION
Vermögen: 6 Mio $ am 31.05.2026
Profil
Damian deGoa is currently Chief Executive Officer & Director at Liquidia Technologies, Inc. since 2020 and serves as an Independent Director at Liquidia Corp.
since 2020.
Formerly, Mr. deGoa was Chief Executive Officer & Director at Liquidia PAH LLC from 2018 to 2020, Director at Breas Medical AB from 2017 to 2020, Managing Director at PBM Capital Group LLC from 2012 to 2018, and Head of International Business Development at Perrigo Co. from 2007 to 2012.
Education includes an MBA from DePaul University and an undergraduate degree from the University of Michigan.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.06.2026 | 92’353 ( 0.1% ) | 6 Mio $ | 31.05.2026 |
Aktive Positionen von Damian deGoa
| Unternehmen | Position | Beginn |
|---|---|---|
| LIQUIDIA CORPORATION | Direktor/Vorstandsmitglied | 14.12.2020 |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Vorstandsvorsitzender | 14.12.2020 |
Ehemalige bekannte Positionen von Damian deGoa
| Unternehmen | Position | Ende |
|---|---|---|
RareGen LLC
 RareGen LLC Miscellaneous Commercial ServicesCommercial Services Provides investment and commercialization for rare disease pharmaceutical products | Vorstandsvorsitzender | 01.11.2020 |
Breas Medical AB
 Breas Medical AB Medical SpecialtiesHealth Technology Manufactures home respiratory ventilators and sleep apnea products | Vorstandsvorsitzender | 01.02.2020 |
PBM Capital Group LLC
 PBM Capital Group LLC Investment ManagersFinance PBM Capital Group invests in companies located in the United States. The firm targets companies operating in the fields of pharmaceutical and life sciences industries. They provide financing for buyout and early stage capital requirements. | Vorstandsvorsitzender | 01.08.2018 |
Perrigo Co.
 Perrigo Co. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets pharmaceutical and nutritional products | Corporate Officer/Principal | 01.12.2012 |
Ausbildung von Damian deGoa
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Perrigo Co.
Perrigo Co. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets pharmaceutical and nutritional products | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
DePaul University
 DePaul University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Breas Medical AB
Breas Medical AB Medical SpecialtiesHealth Technology Manufactures home respiratory ventilators and sleep apnea products | Health Technology |
PBM Capital Group LLC
PBM Capital Group LLC Investment ManagersFinance PBM Capital Group invests in companies located in the United States. The firm targets companies operating in the fields of pharmaceutical and life sciences industries. They provide financing for buyout and early stage capital requirements. | Finance |
RareGen LLC
RareGen LLC Miscellaneous Commercial ServicesCommercial Services Provides investment and commercialization for rare disease pharmaceutical products | Commercial Services |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Wählen Sie MarketScreener 
